Stephanie Dulucq

Stephanie Dulucq

UNVERIFIED PROFILE

Are you Stephanie Dulucq?   Register this Author

Register author
Stephanie Dulucq

Stephanie Dulucq

Publications by authors named "Stephanie Dulucq"

Are you Stephanie Dulucq?   Register this Author

28Publications

672Reads

32Profile Views

Novel analytical methods to interpret large sequencing data from small sample sizes.

Hum Genomics 2019 Aug 30;13(1):41. Epub 2019 Aug 30.

Laboratory of Mammary and Leukaemic Oncogenesis, Inserm U1218 ACTION, Bergonié Cancer Institute, University of Bordeaux, 146 rue Léo Saignat, bâtiment TP 4ème étage, case 50, 33076, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40246-019-0235-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717342PMC
August 2019

[Recommendations from the French CML Study Group (Fi-LMC) for BCR-ABL1 kinase domain mutation analysis in chronic myeloid leukemia].

Bull Cancer 2019 Jul 26. Epub 2019 Jul 26.

Siège social, institut Bergonié, Groupe d'étude français pour la leucémie myéloïde chronique Fi-LMC, 229, cours de l'Argonne, 33000 Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.05.011DOI Listing
July 2019

Hemophagocytosis by blasts in acute lymphoblastic leukemia.

Blood Res 2019 Mar 21;54(1). Epub 2019 Mar 21.

Laboratoire d'Hématologie, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2019.54.1.2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439298PMC
March 2019

Molecular monitoring of patients with ETV6-PDGFRB rearrangement: Implications for therapeutic adaptation.

Br J Haematol 2018 07 9;182(1):148-152. Epub 2017 May 9.

Laboratoire d'Hématologie, CHU de Brest and INSERM U1078, Université de Bretagne Occidentale, Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14748DOI Listing
July 2018

Deep molecular responses for treatment-free remission in chronic myeloid leukemia.

Cancer Med 2016 09 1;5(9):2398-411. Epub 2016 Jul 1.

Bergonié Cancer Institute, INSERM Unit 916, University of Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055167PMC
September 2016

A case of acute promyelocytic leukaemia with unusual cytological features and a ZBTB16-RARA fusion gene.

Br J Haematol 2016 08 15;174(4):502. Epub 2016 Jun 15.

Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.14198
Publisher Site
http://dx.doi.org/10.1111/bjh.14198DOI Listing
August 2016

Transient abnormal myelopoiesis (TAM) in a neonate without Down syndrome.

Br J Haematol 2015 Jan 13;168(1). Epub 2014 Oct 13.

Laboratoire d'Hematologie, Centre Hospitalier Universitaire, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13166DOI Listing
January 2015

Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study.

PLoS One 2013 30;8(9):e75486. Epub 2013 Sep 30.

AP-HP (Assistance Publique des Hôpitaux de Paris), Hôpital Bichat, Laboratoire de Parasitologie-Centre National de Référence du Paludisme, Paris, France ; Université Paris Descartes, UMR 216, Paris, France ; Institut de Recherche pour le Développement, UMR 216, Paris, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0075486PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787089PMC
May 2014

Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.

Expert Opin Drug Metab Toxicol 2014 May 27;10(5):699-719. Epub 2014 Mar 27.

University Health Center Bordeaux, Heamatology Laboratory , Bordeaux , France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/17425255.2014.89
Publisher Site
http://dx.doi.org/10.1517/17425255.2014.893294DOI Listing
May 2014

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells.

Blood 2011 Aug 5;118(8):2211-21. Epub 2011 Jul 5.

Hématopoïèse Leucémique et Cible Thérapeutique, Inserm U1035, Université Victor Ségalen, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-10-313692DOI Listing
August 2011

The pharmacogenetics of imanitib.

Genome Med 2010 Nov 30;2(11):85. Epub 2010 Nov 30.

Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Université Victor Ségalen Bordeaux 2, Inserm U876, CHU Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016627PMC
November 2010

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

Blood 2008 Sep 4;112(5):2024-7. Epub 2008 Jun 4.

Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Université Victor Ségalen Bordeaux 2, Inserm U876, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-03-147744DOI Listing
September 2008

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL.

Blood 2008 Apr 20;111(7):3692-700. Epub 2007 Dec 20.

Research Center, Centre Hospitalier Universitaire Mère-Enfant, Sainte-Justine, Department of Pediatrics, University of Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-09-110593DOI Listing
April 2008